A Study of Continuous Blood Pressure Monitoring in Healthy Participants

The main purpose of this study in healthy participants is to find out whether the traditional ambulatory blood pressure monitor (ABPM) and newer wearable devices (EmbracePlus smartwatch device, Biobeat chest patch device, and Aktiia wrist device) will accurately pick up changes in blood pressure caused by 2 different medications (propranolol and pseudoephedrine). The study will last about 29 days excluding the screening period of 28 days.

Inclusion Criteria:Are overtly healthy males or femalesHave a body mass index (BMI) of 18.0 to 35 kilograms/square meter (kg/m2), inclusive at screeningHave blood pressure, pulse rate, blood and urine laboratory test results that are acceptable for the studyHave given written informed consent approved by Lilly and the ethical review board governing the siteExclusion Criteria:Have or used to have health problems that, in the opinion of the doctor, could make it unsafe to participate, or could interfere with understanding the results of the studyHave history of sensitive skin or chronic skin conditions, like eczemaRegular use of known drugs of abuseAre women who are pregnant or lactatingHave known allergies to medications used in the study